EQT, UnitedHealth, Clearway Energy And More On CNBC’s ‘Final Trades’
TV market experts picked GPIQ, UNH, CWEN and EQT; UNH reports Oct. 13, with analysts expecting $4.14 EPS and $111.49B revenue.
Stocks · News reference
Goldman Sachs Nasdaq-100 ETF, Nutrien And More: CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Bryn Talkington, managing partner of Requisite Capital Management, said Goldman Sachs Nasdaq-100 Premium Income ETF (NASDAQ: GPIQ) has a 10.5% yield.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
CNBC Halftime Report Final Trades: UnitedHealth Group, EQT, Clearway Energy, Goldman Sachs Nasdaq-100 Premium Income ETF
CNBC Halftime Report Final Trades: Nutrien, Goldman Sachs Nasdaq-100 Premium Income ETF, GXO Logistics, iShares U.S. Financial ETF
Goldman Sachs Upgrades GXO Logistics to Buy, Maintains Price Target to $61
Goldman Sachs analyst Patrick Creuset upgrades GXO Logistics (NYSE:GXO) from Neutral to Buy and maintains the price target from $61 to $61.
The First Pure-Play Humanoid Robot Stock Is About to Go Public. Here's What Investors Need to Know About Agility Robotics.
Agility Robotics, maker of the Digit humanoid robot, is going public through a SPAC merger with Churchill Capital Corp XI at a $2.5 billion valuation. While the company has impressive technology and $300 million in orders, it lost $140 million on only $1.8 million in sales last year. The stock is expected to be highly volatile as investors debate whether humanoid robots will mainstream within weeks or take a decade, with most tech IPOs declining in their first months after going public.
Susquehanna Maintains Positive on GXO Logistics, Lowers Price Target to $60
Susquehanna analyst Bascome Majors maintains GXO Logistics (NYSE:GXO) with a Positive and lowers the price target from $62 to $60.